New combination of a betablocker and a cholesterol-lowering agent
CA 2403160 A1 · Owner: Wiklund, Olov · Inventors: Bondjers, Goran; Wikstrand, John; Wiklund, Olov
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to pharmaceutical formulations comprising a betablocker and a cholesterol-lowering agent in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier as well as a kit of , parts, a method for treatment and use of the formulations for the prophylactic or therapeutic treatment of atherosclerosis hypercholesterolemia and , hyperlipoproteinemia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.